Biotechnology

3000+ Companies
More info
Parent markets
Sibling markets
Related markets
3000+ companies in Biotechnology
Show all
Twitter

Twitter

Video Streaming +140
AstraZeneca

AstraZeneca

Biotechnology +1
Merck

Merck

Health Care +2
23andMe

23andMe

Biotechnology +3
Pfizer Belgium

Pfizer Belgium

Medical +2
Roche

Roche

Biotechnology +3
Celgene Corporation

Celgene Corporation

Medical +1
Gilead Sciences

Gilead Sciences

Biotechnology
Biogen

Biogen

Biotechnology
Amgen Inc.

Amgen Inc.

Manufacturing +2
AbbVie

AbbVie

Biotechnology +1
ProMIS Neurosciences

ProMIS Neurosciences

Biotechnology
Neuralink

Neuralink

Biotechnology
GlaxoSmithKline

GlaxoSmithKline

Health and Wellness +2
Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

Biotechnology +1
All companies in Biotechnology
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2021
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

News

Funding rounds

Acquisitions

Companies

Investors

Filter companies
21 Jan 2021
Eli
Eli
CAD $1,900,000
Seed fund
Real Ventures, Techstars, Vectr, +4

Eli raises $1.9 million CAD in seed funding to develop at-home hormone monitoring tech

BetaKit
19 Jan 2021
OncoHost
OncoHost
$8,000,000
Venture capital (Series B)
OurCrowd

OncoHost raises $8 million to develop AI that predicts cancer treatment responses

VentureBeat
14 Jan 2021
AltPep
AltPep
$23,100,000
Venture capital (Series A)
Matrix Capital Management, Alexandria Venture Investments

Seattle biotech startup AltPep raises $23.1M to tackle Alzheimer’s and related diseases

GeekWire
12 Jan 2021
Delfi Diagnostics
Delfi Diagnostics
$100,000,000
Venture capital (Series A)
Menlo Ventures, Foresite Capital, Rock Springs Capital, +7

Delfi Diagnostics Nets $100M in Series A Financing, Plans Multi-Cancer Screening Test

neurons.AI
08 Jan 2021
Visen Pharmaceuticals
Visen Pharmaceuticals
$150,000,000
Venture capital (Series B)
OrbiMed, Cormorant Asset Management, Vivo Capital, +7

Sequoia China Leads $150 Million Round In Drug Developer Visen Pharma – China Money Network

ChinaMoneyNetwork
07 Jan 2021
LifeMine Therapeutics
LifeMine Therapeutics
$50,000,000
Venture capital (Series B)

LifeMine Therapeutics Announces $50 Million Series B Financing

neurons.AI
06 Jan 2021
New Wave Foods
New Wave Foods
$18,000,000
Venture capital (Series A)
New Enterprise Associates, Tyson Ventures, Evolution VC Partners

Plant-Based Shellfish Company New Wave Foods Raises $18 Million

Pulse 2.0
04 Jan 2021
Color
Color
$167,000,000
Venture capital (Series D)
T. Rowe Price, Viking Global Investors, General Catalyst

Color: $167 Million Series D Funding And $1.5 Billion Valuation

Pulse 2.0
30 Dec 2020
E Green Global
E Green Global
$9,200,000
Seed fund
YD-SK-KDB Social Value Fund

E Green Global bags US$9.2M from Korean social impact VC fund to expand its agritech facility | e27

e27: Asia tech news
30 Dec 2020
23andMe
23andMe
$82,500,000
Venture capital (Series F)
Sequoia Capital, NewView Capital

Genetic testing company 23andMe raises $82.5M from Sequoia and NewView Capital

SiliconANGLE
28 Dec 2020
H1
H1
$58,000,000
Venture capital (Series B)
Menlo Ventures, Lux Capital, Lead Edge Capital, +4

Healthcare Ecosystem Platform H1 Raises $58 Million In Series B

Pulse 2.0
27 Dec 2020
Enveda Biosciences
Enveda Biosciences
$4,900,000
Seed fund
True Ventures, Wireframe Ventures, Village Global, +1

Enveda Biosciences Raises $4.9 Million To Engineer Drugs From Nature

Pulse 2.0